vialroom

#retatrutide 2026-05-02

Saturday34 messages7 participantstimes are UTC
Highlights from this day
  • gradient_greg — low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom, ask me again in a month 18:04
  • noct.titrate — quick one buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely 18:30
  • gradient_greg — reconstituted the 30 vial to 10mg/ml specifically so i could take 1.7 without measuring crumbs, ill dig out the number 18:47
  • VialBot — Inter-lab diff for lot B-0114: 98.6% vs 98.1%. Within expected range. 19:18
  • non_scale_win — stepping in 7.5 increments instead of doubling is the only thing i would change if i started again 19:54

sat at 12 for 6 months rather than climbing and it kept working, so i never went up

appetite suppression at 15 was stronger than my tirzepatide experience at a comparable point

GG

low and slow here means smaller steps than i ever used on tirzepatide, thats the received wisdom, ask me again in a month

IS

held at 15 for 14 months and it never plateaued for me, which i cant explain

the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me

GG

i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind

NT

quick one buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely

NT

came off at 14 weeks because my resting rate stayed elevated and i didnt like it

TRIUMPH is phase 3

IS

genuine question blood pressure stayed flat for me while heart rate moved, which i didnt expect

VB

Inter-lab diff for lot B-0114: 98.6% vs 98.1%. Within expected range.

NT

the purity spread across lots worries me more than the molecule does

NS

stepping in 7.5 increments instead of doubling is the only thing i would change if i started again

⚠️1

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial, we shall see

phase 2 was still trending at the end which is why the phase 3 readout matters more than usual

GG

while im here the honest position is this has less human evidence behind it than anything else discussed here

TW

there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists

EE

my resting rate went up 5 bpm in the first month and came back most of the way by month 24

triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history

settled by month three

mine went up too

energy expenditure isnt something i could feel, though my sleep tracker disagreed with me

the heart rate thing is real enough that i mention it whenever someone asks about starting

[edited]